Raj Patil
Net worth: 33 650 $ as of 30/07/2026
Net worth: 33 650 $ as of 30/07/2026
Raj Patil is currently Chief Scientific Officer at OKYO Pharma Ltd. since 2021.
Former positions include Associate Director-Research at Alcon Laboratories, Inc. from 2004 to 2011, Associate Director-Research at Novartis Institutes for Biomedical Research, Inc. from 2011 to 2013, Assistant Professor at the University of Washington from 1992 to 2001, Associate Professor at the University of Nebraska Medical Center from 2001 to 2004, Vice President-Advanced Ocular Delivery Systems at iVeena Delivery Systems, Inc. from 2013 to 2018, Vice President-Research & Development at Ora, Inc. from 2020 to 2021, and Associate Professor at Duke-NUS Graduate Medical School Singapore from 2011 to 2017.
Education includes a doctorate from National Chemical Laboratory.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OKYO PHARMA LIMITED 0.04% | 26/07/2026 | 20,030 ( 0.04% ) | 33 650 $ | 30/07/2026 |
| Companies | Position | Start |
|---|---|---|
| WEST AFRICAN MINERALS CORP | Chief Tech/Sci/R&D Officer | 20/09/2018 |
| Companies | Position | End |
|---|---|---|
Ora, Inc.
Ora, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products and provides clinical research services | Chief Tech/Sci/R&D Officer | 28/02/2021 |
iVeena Delivery Systems, Inc.
iVeena Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology Manufactures eye drops | Corporate Officer/Principal | 31/12/2017 |
Duke-NUS Graduate Medical School Singapore
Duke-NUS Graduate Medical School Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 30/11/2017 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 31/12/2012 |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Corporate Officer/Principal | 31/05/2011 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
OKYO Pharma Ltd.
OKYO Pharma Ltd. BiotechnologyHealth Technology Develops next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Health Technology |
University of Nebraska Medical Center
University of Nebraska Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
National Chemical Laboratory
National Chemical Laboratory Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ora, Inc.
Ora, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products and provides clinical research services | Health Technology |
Duke-NUS Graduate Medical School Singapore
Duke-NUS Graduate Medical School Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iVeena Delivery Systems, Inc.
iVeena Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology Manufactures eye drops | Health Technology |
Select your edition
All financial news and data tailored to specific country editions